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(54) Cheese whey treatment and valorisation process with continuous ethanolic fermentation
(57) The invention deals with a process used for
Cheese whey treatment and valorisation.
The plant where this process is applied includes
three main components - an ultraﬁltration unit, a biore-
actor and a destillation unit. Final products of this proc-
ess are a whey protein concentrate and ethanol.
Ultraﬁltration and distillation units are similar to the
ones being used in other cheese whey treatment plants.
The innovative characteristics of this process lie on
the design of the bioreactor and its operation mode and
on the microorganism being used. The bioreactor, with
a total volume of 1000 litters at the installed scale, is a
concentric tube internal loop air-lift bioreactor with a
degassing zone at the top; the mode of operation is con-
tinuous; the lactose fermenting used yeast strain has
the ability to form ﬂocs. By using a ﬂocculating yeast
strain and operating the bioreactor continuously a
higher productivity in lactose conversion to ethanol may
be achieved with a simultaneous reduction in the vol-
ume of residual solids. This process allows for a 90%
reduction in the pollution caused by cheese whey dis-
posal.
The innovative character of this invention lies on the
use a continuously operating bioreactor with a new
design. The integration of the fermentation unit in the
overall cheese whey treatment and valorisation process
forces the extension of the request for protection of the
patent to the entire process.
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Description
[0001] This invention describes a process for a
cheese whey treatment and valorisation plant that incor-
porates a continuously operating concentric internal
tube airlift bioreactor with a sedimentation zone at the
tope. A lactose fermenting yeast with the ability to form
ﬂoes is used. In this process a high protein concentra-
tion efﬂuent for further processing and food grade etha-
nol are obtained, with a reduction in the cheese whey
pollutant charge.
[0002] The main objective of this invention is the
implementation of a process that, when compared with
existing plants, allows for the obtention of a higher pro-
ductivity in the alcoholic fermentation with decreased
operating costs.
[0003] The biorector used in the fermentation proc-
ess is the main innovative characteristic of this inven-
tion, since all the others operations involved are similar
to already existing processes.
[0004] The proposed unit for cheese whey valorisa-
tion is implemented at pilot plant sacle. It includes the
following processes: after being stored in a retention
tank, cheese whey is fed to a 40000 MWCO organic
membranes ultraﬁltration unit whwre two fractions are
obtained - the permeate and the retentate. Whenever
necessary, cheese whey is pasteurised. The protein
rich fraction - retentate - is stored in a tank for further
processing. The deproteinized cheese whey is fed con-
tinuously to the bioreactor where fermentation occurs.
The outlet ﬂow of the biorector, with a 2.5/(w/v) ethanol
content is stored in a retention tank for destillation in a
batch distillation unit. The solid residues of the destilla-
tion process as well as the biomass purged from the
bioreactor are treated in an existing solid wastes treat-
ment plant.
[0005] In ﬁg. 1, the bioreactor used in the conver-
sion of lactose from deproteinized cheese whey to eth-
anol is presented. Dimensions are also indicated.
[0006] The bioreactor has a total volume of 1000
litres and is composed of two main zones: a central
body formed by two concentric tubes and a decantation
zone (2). The air used to promote biomass circulation is
injected at the bottom of the interior tube (3), after ade-
quate sterilisation. Air is fed through a perforated disc
(diameter - 130 mm) with 4 mm holes.
[0007] Inside and outside tube diameters are,
respectively, 180 and 392 mm, in order to assure an
adequate biomass circulation for high cell densities.
[0008] In the top part (2) degassing of the liquid
phase and biomass decantation occur. Biomass is recir-
culated to the central body of the bioreactor. In this way,
biomass accumulation is improved and the biomass in
the outﬂow is minimised. When an excessive biomass
accumulation occurs, purges are done.
[0009] Biomass retention is improved by the use of
a retention device - bafﬂe - installed in the outlet of the
bioreactor.
[0010] Temperature and pH control systems are
also installed.
[0011] A lactose fermenting yeast - Kluyveromyces
marxianus ATCCC 10022 - with the ability to form ﬂoes
in the cintinuously operating bioreactor is used. This
yeast property allows for the obtention of high biomass
concentrations in the biorector.
[0012] The conjugation of these two factors - use of
a ﬂocculating yeast strain and an innovative bioreactor
design - makes possible to continuously ferment lactose
to ethanol with higher productivities that the conven-
tional batch processes.
Claims
1. Cheese whey treatment and valorisation process
where conversion of lactose to ethanol is done
using a ﬂocculating lactose fermenting yeast - Kluy-
veromyces marxianus ATCCC 10022 at the top.
2. Cheese whey treatment and valorisation process
according to 1, characterised by the use of a contin-
uous fermentation process that allows for the
obtention of 12 gethanol1-
1hr-1 productivities.
3. Cheese whey treatment and valorization process
according to 1, characterized by the use of a biore-
actor with an enlarged decantation zone at the top,
forming a 60° angle with the main body of the reac-
tor, so that an efﬁcient biomass retention inside the
bioreactor is assured and biomass concentration in
the outﬂow is minimized.
4. Cheese whey treatment and valorisation processo
according to 1, characterised by the use of a con-
centric tubes airlift bioreactor. Air is injected in the
bottom of the internal tube being 2.18 the diameter
ratio between internal and external tubes.
5. Cheese whey treatment and valorisation process
according to 1, 3 and 4, characterised by its simple
construction and operating mode due to the
absence of mechanical devices.
6. Cheese whey treatment and valorization process
according to 1, characterized by the use of ﬂoccu-
lating lactose fermentation yeast - Kluyveromyces
marxianus ATCCC 10022 - that biomass retention
in the bioreactor.
7. Cheese whey treatment and valorization process
according to 1, 3 and 5, characterised by the place-
ment of a bafﬂe in the decantation zone near the
efﬂuent outlet to increase biomass retention in the
bioreactor.
8. Cheese whey treatment and valorisation process
according to 1 to 7, characterised by the use of a
1 2
5
10
15
20
25
30
35
40
45
50
55
EP 1 041 153 A1
3
continuous bioreactor with higher productivities and
smaller investment and operating costs that make
this process an interesting alternative to existing
ones.
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